Compositions and methods for treating tumors, fibrosis, and pulmonary alveolar proteinosis
Abstract:
The present disclosure provides pharmaceutical compositions and methods useful for modulating angiogenesis and for inhibiting metastasis, tumors, pulmonary alveolar proteinosis, and fibrosis in a mammalian tissue. Pharmaceutical compositions and methods include inhibitors of LOXL2 expression and activity, such as shRNA targeting LOXL2.
Information query
Patent Agency Ranking
0/0